Mannkind Corp (MNKD)

$3.92 0.08 (2.00%)

16:00 EDT MNKD Stock Quote Delayed 30 Minutes

MNKD Stock: The Disappointing FDA News That Has MannKind Shares Diving Today

By William White, InvestorPlace Writer Oct 18, 2021

MannKind (MNKD) stock is taking a beating on Monday after releasing an update to investors concerning news from the FDA for Tyvaso DPI.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

The 6 Best Penny Stocks to Buy for September

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Volume:

Previous Close -

Market Cap 987.05M

PE Ratio -12.25

EPS -0.32

Volume (Avg. Vol.) 3.26M

Day's Range $3.90 - $4.01

52-Week Range $2.49 - $5.44

Dividend & Yield N/A (N/A)

MNKD Stock Predictions, Articles, and Mannkind Corp News

From InvestorPlace
From the Web

MannKind Is Crushing It, but Beware or You’ll Be Crushed

By David Moadel, InvestorPlace Contributor Jun 24, 2020

Before you consider going all in on MNKD stock, consider that the company is itself going all in on one product, and that comes with risks.

5 Dollar Stocks to Buy Now

By William Roth, InvestorPlace Market Strategist Sep 10, 2019

Signs are pointing to potential big gains for penny stocks in the coming days. These 5 dollars stocks are worth owning now.

5 Low-Priced Biotech Stocks to Take Advantage of the Market Rout

By Aaron Levitt, InvestorPlace Contributor Oct 22, 2018

Look to low-priced biotech stocks for some big-time bargains. Here are five great ones to buy today.

New Development Partnership Could Pay Off Big for MannKind Stock

By Chris Lau, InvestorPlace Contributor Sep 5, 2018

MannKind scored a collaboration deal with biotechnology giant, United Therapeutics. This development partnership could pay off big.

Why MannKind Stock Is Skyrocketing Today

By William White, InvestorPlace Writer Sep 4, 2018

MannKind (MNKD) stock was flying high on Tuesday following the announcement of a $45-million deal with United Therapeutics (UTHR).

MannKind Stock Is One Step Away From Obliteration

By Josh Enomoto, InvestorPlace Contributor Aug 6, 2018

MNKD stock collapsed after disastrously poor Q2 earnings, but the real story is that MannKind now faces a bankruptcy threat.

MannKind Corporation (MNKD) Stock Slides Despite Q2 Revenue Growth

By Karl Utermohlen, InvestorPlace Writer Aug 2, 2018

MannKind Corporation (MNKD) stock was sliding after the bell following the company's quarterly earnings report, which included a year-over-year Afrezza revenue growth of 142%.

Don’t Buy MannKind Corporation Stock Under Any Circumstances

By Chris Fraley, InvestorPlace Contributor Feb 12, 2018

With a depressed share price, sales set to double this year, and a traditionally high-growth sector, it can be tempting to view MannKind Corp. (MNKD) as a bargain. Don’t make that mistake.

Is MannKind Corporation Stock Really Worth the Risk?

By Joseph Hargett, InvestorPlace Contributor Jan 26, 2018

Volatility has send MannKind stock's options prices through the roof. You could sell option premium here, but is MNDK worth the risk?

Metrics for Earnings Visibility Keep Mannkind (MNKD) a Sell at recent price of $3.8

By Portfolio Grader Jan 26, 2018

The Sell recommendation for Mannkind Corp is the outcome of an analytical process that is proprietary which generated conclusions that were above average in 2 areas: an economic sector rated above average in attractiveness, and a mathematical computation of risk/reward that is better than average; and produced below average results in 4 areas: an industry group rated below average in attractiveness, a ranking in the company's sector that is in the middle third, ranking in the company's industry group that is in the middle third-below average, and analytical scoring that is well below average.